Technology

STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug

2026-10-09 15:41
634 views
STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug

Adobe By Meghana Keshavan and Jason MastOct. 9, 2026 Meghana Keshavan[email protected]Meghana Keshavan covers biotech and contributes to The Readout newsletter.Jason Mast[email protected]Jason is a ge...

Close up of an eye
Adobe

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

This is the Readout. Please read it.

And don’t miss us too much Monday, when the newsletter will be paused for the holiday. We’ll be back in your inbox Tuesday.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
Source: Meghana Keshavan and Jason Mast · www.statnews.com